Kymera Therapeutics, Inc. (KYMR) operating KPIs
KYMRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/30226% above fair value
$126.63+4.03 (+3.29%)
Close on Oct 30, 2026Market cap $10.53BP/E –Yield –
KPIs
Operating metrics that drive Kymera Therapeutics's business
Coming soon
This tab will track the numbers specific to Kymera Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.